Publications by authors named "Valerie Scherfeld"
Article Synopsis
- The study examines outcomes of two pregnancies with suspected preeclampsia, focusing on the diagnostic value of clinical signs and the sFlt-1 to PlGF ratio in predicting adverse outcomes.
- Out of 1928 screened patients, 1117 were included, with 84 women having suspected preeclampsia in both pregnancies.
- Results show that adverse outcome prevalence decreased from 27.4% in the first to 17.9% in the second pregnancy, and the first pregnancy's sFlt-1/PlGF ratio did not predict outcomes in the second pregnancy, indicating these markers are short-term assessment tools.
Introduction: The objective of this retrospective study was to compare the predictive performance of the soluble fms-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio alone or in a multi-marker regression model for preeclampsia-related maternal and/or fetal adverse outcomes in women >34 weeks of gestation.
Methods: We analyzed the data collected from 655 women with suspected preeclampsia. Adverse outcomes were predicted by multivariable and univariable logistic regression models.